Health Economics And Outcomes Research (HEOR) Services Comprehensive Study by Type (Economic Modelling/Evaluation, Real-world Data Analysis & Information Systems, Clinical Outcome, Market Access Solutions & Reimbursement), Service Provider (Consultancy, Contract Research Organizations, Others), End User (Healthcare Providers, Healthcare Payers, Biotech/Pharma Companies, Government Organizations) Players and Region - Global Market Outlook to 2030

Health Economics And Outcomes Research (HEOR) Services Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Health Economics And Outcomes Research (HEOR) Services
Health Economics And Outcomes Research (HEOR) Services play an increasingly vital role in a drug’s approval and reimbursement with payers. It works with a pharmaceutical or life science company that is tasked with generating evidence of the value of a new drug or other intervention for reimbursement and healthcare payers. HEOR services focus on the economic impact of treatments, diseases, and conditions, including the direct costs of medical expenditures and indirect costs. It helps decision-makers such as health ministries, governments, clinicians & payers to adequately compare and choose among the available options. The market is expected to grow in the future due to an increasing pressure to control the rising cost of healthcare and a greater need to demonstrate the value of health care treatments in addition to their efficacy.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Health Economics And Outcomes Research (HEOR) Services market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Avalon Health Economics (United States), McKesson Corporation (United States), Cardinal Health, Inc. (United States), Medlior Health Outcomes Research Ltd (Canada), Optum (United States), PharmaLex (Germany), Pharmaceutical Product Development (PPD) (United States), IQVIA (United States) and RTI Health Solutions (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Health Economics And Outcomes Research (HEOR) Services market by Type (Economic Modelling/Evaluation, Real-world Data Analysis & Information Systems, Clinical Outcome and Market Access Solutions & Reimbursement) and Region.



On the basis of geography, the market of Health Economics And Outcomes Research (HEOR) Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Health Economics And Outcomes Research (HEOR) Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Outsourcing of R&D Activities

Market Growth Drivers:
Increasing Number of Clinical Trials Globally, Focus of Pharma & Biotech Companies on New Drug Development and Increasing R&D Expenditure Worldwide

Challenges:
Lack of Skilled Healthcare Professionals in Developing and Underdeveloped Economies

Restraints:
Regulatory Pressure on HEOR Service Providers

Opportunities:
Rising Demand for Secured Services including Clinical and Preclinical Testing as well as Regulatory Approvals and Growth of Healthcare IT and Analytic Tools

Market Leaders and their expansionary development strategies
In Feb 2021, PharmaLex, a provider of specialized services for the pharma, biotech, and medtech industries, announced on Feb. 24, 2021, that it has completed its acquisition of ERA Consulting, a consulting firm that provides product development and regulatory support.
In May 2019, ICON announced the release of its web-based patient engagement platform, to provide patients with study-specific information and connectivity with the nearest investigative site. The solution supplements patient recruitment outreach by sites and increases the visibility of potential study participants for sponsors and sites.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Health Economics And Outcomes Research (HEOR) Services Provider, Government Regulatory and Research Organizations, Venture Capitalists and Private Equity Firms and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Economic Modelling/Evaluation
  • Real-world Data Analysis & Information Systems
  • Clinical Outcome
  • Market Access Solutions & Reimbursement
By Service Provider
  • Consultancy
  • Contract Research Organizations
  • Others

By End User
  • Healthcare Providers
  • Healthcare Payers
  • Biotech/Pharma Companies
  • Government Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Clinical Trials Globally
      • 3.2.2. Focus of Pharma & Biotech Companies on New Drug Development
      • 3.2.3. Increasing R&D Expenditure Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Healthcare Professionals in Developing and Underdeveloped Economies
    • 3.4. Market Trends
      • 3.4.1. Growing Outsourcing of R&D Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Health Economics And Outcomes Research (HEOR) Services, by Type, Service Provider, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Health Economics And Outcomes Research (HEOR) Services (Value)
      • 5.2.1. Global Health Economics And Outcomes Research (HEOR) Services by: Type (Value)
        • 5.2.1.1. Economic Modelling/Evaluation
        • 5.2.1.2. Real-world Data Analysis & Information Systems
        • 5.2.1.3. Clinical Outcome
        • 5.2.1.4. Market Access Solutions & Reimbursement
      • 5.2.2. Global Health Economics And Outcomes Research (HEOR) Services by: Service Provider (Value)
        • 5.2.2.1. Consultancy
        • 5.2.2.2. Contract Research Organizations
        • 5.2.2.3. Others
      • 5.2.3. Global Health Economics And Outcomes Research (HEOR) Services by: End User (Value)
        • 5.2.3.1. Healthcare Providers
        • 5.2.3.2. Healthcare Payers
        • 5.2.3.3. Biotech/Pharma Companies
        • 5.2.3.4. Government Organizations
      • 5.2.4. Global Health Economics And Outcomes Research (HEOR) Services Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Health Economics And Outcomes Research (HEOR) Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Avalon Health Economics (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. McKesson Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cardinal Health, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medlior Health Outcomes Research Ltd (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Optum (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. PharmaLex (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Pharmaceutical Product Development (PPD) (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. IQVIA (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. RTI Health Solutions (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Health Economics And Outcomes Research (HEOR) Services Sale, by Type, Service Provider, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Health Economics And Outcomes Research (HEOR) Services (Value)
      • 7.2.1. Global Health Economics And Outcomes Research (HEOR) Services by: Type (Value)
        • 7.2.1.1. Economic Modelling/Evaluation
        • 7.2.1.2. Real-world Data Analysis & Information Systems
        • 7.2.1.3. Clinical Outcome
        • 7.2.1.4. Market Access Solutions & Reimbursement
      • 7.2.2. Global Health Economics And Outcomes Research (HEOR) Services by: Service Provider (Value)
        • 7.2.2.1. Consultancy
        • 7.2.2.2. Contract Research Organizations
        • 7.2.2.3. Others
      • 7.2.3. Global Health Economics And Outcomes Research (HEOR) Services by: End User (Value)
        • 7.2.3.1. Healthcare Providers
        • 7.2.3.2. Healthcare Payers
        • 7.2.3.3. Biotech/Pharma Companies
        • 7.2.3.4. Government Organizations
      • 7.2.4. Global Health Economics And Outcomes Research (HEOR) Services Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Health Economics And Outcomes Research (HEOR) Services: by Type(USD Million)
  • Table 2. Health Economics And Outcomes Research (HEOR) Services Economic Modelling/Evaluation , by Region USD Million (2018-2023)
  • Table 3. Health Economics And Outcomes Research (HEOR) Services Real-world Data Analysis & Information Systems , by Region USD Million (2018-2023)
  • Table 4. Health Economics And Outcomes Research (HEOR) Services Clinical Outcome , by Region USD Million (2018-2023)
  • Table 5. Health Economics And Outcomes Research (HEOR) Services Market Access Solutions & Reimbursement , by Region USD Million (2018-2023)
  • Table 6. Health Economics And Outcomes Research (HEOR) Services: by Service Provider(USD Million)
  • Table 7. Health Economics And Outcomes Research (HEOR) Services Consultancy , by Region USD Million (2018-2023)
  • Table 8. Health Economics And Outcomes Research (HEOR) Services Contract Research Organizations , by Region USD Million (2018-2023)
  • Table 9. Health Economics And Outcomes Research (HEOR) Services Others , by Region USD Million (2018-2023)
  • Table 10. Health Economics And Outcomes Research (HEOR) Services: by End User(USD Million)
  • Table 11. Health Economics And Outcomes Research (HEOR) Services Healthcare Providers , by Region USD Million (2018-2023)
  • Table 12. Health Economics And Outcomes Research (HEOR) Services Healthcare Payers , by Region USD Million (2018-2023)
  • Table 13. Health Economics And Outcomes Research (HEOR) Services Biotech/Pharma Companies , by Region USD Million (2018-2023)
  • Table 14. Health Economics And Outcomes Research (HEOR) Services Government Organizations , by Region USD Million (2018-2023)
  • Table 15. South America Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2018-2023)
  • Table 16. South America Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 17. South America Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 18. South America Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 19. Brazil Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 20. Brazil Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 21. Brazil Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 22. Argentina Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 23. Argentina Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 24. Argentina Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 25. Rest of South America Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 27. Rest of South America Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 28. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 31. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 32. China Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 33. China Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 34. China Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 35. Japan Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 36. Japan Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 37. Japan Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 38. India Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 39. India Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 40. India Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 41. South Korea Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 42. South Korea Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 43. South Korea Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 44. Taiwan Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 45. Taiwan Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 46. Taiwan Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 47. Australia Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 48. Australia Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 49. Australia Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 53. Europe Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2018-2023)
  • Table 54. Europe Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 55. Europe Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 56. Europe Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 57. Germany Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 58. Germany Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 59. Germany Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 60. France Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 61. France Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 62. France Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 63. Italy Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 64. Italy Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 65. Italy Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 66. United Kingdom Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 67. United Kingdom Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 68. United Kingdom Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 69. Netherlands Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 70. Netherlands Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 71. Netherlands Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 72. Rest of Europe Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 74. Rest of Europe Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 75. MEA Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2018-2023)
  • Table 76. MEA Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 77. MEA Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 78. MEA Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 79. Middle East Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 80. Middle East Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 81. Middle East Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 82. Africa Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 83. Africa Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 84. Africa Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 85. North America Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2018-2023)
  • Table 86. North America Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 87. North America Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 88. North America Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 89. United States Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 90. United States Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 91. United States Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 92. Canada Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 93. Canada Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 94. Canada Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 95. Mexico Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2018-2023)
  • Table 96. Mexico Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2018-2023)
  • Table 97. Mexico Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2018-2023)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Health Economics And Outcomes Research (HEOR) Services: by Type(USD Million)
  • Table 108. Health Economics And Outcomes Research (HEOR) Services Economic Modelling/Evaluation , by Region USD Million (2025-2030)
  • Table 109. Health Economics And Outcomes Research (HEOR) Services Real-world Data Analysis & Information Systems , by Region USD Million (2025-2030)
  • Table 110. Health Economics And Outcomes Research (HEOR) Services Clinical Outcome , by Region USD Million (2025-2030)
  • Table 111. Health Economics And Outcomes Research (HEOR) Services Market Access Solutions & Reimbursement , by Region USD Million (2025-2030)
  • Table 112. Health Economics And Outcomes Research (HEOR) Services: by Service Provider(USD Million)
  • Table 113. Health Economics And Outcomes Research (HEOR) Services Consultancy , by Region USD Million (2025-2030)
  • Table 114. Health Economics And Outcomes Research (HEOR) Services Contract Research Organizations , by Region USD Million (2025-2030)
  • Table 115. Health Economics And Outcomes Research (HEOR) Services Others , by Region USD Million (2025-2030)
  • Table 116. Health Economics And Outcomes Research (HEOR) Services: by End User(USD Million)
  • Table 117. Health Economics And Outcomes Research (HEOR) Services Healthcare Providers , by Region USD Million (2025-2030)
  • Table 118. Health Economics And Outcomes Research (HEOR) Services Healthcare Payers , by Region USD Million (2025-2030)
  • Table 119. Health Economics And Outcomes Research (HEOR) Services Biotech/Pharma Companies , by Region USD Million (2025-2030)
  • Table 120. Health Economics And Outcomes Research (HEOR) Services Government Organizations , by Region USD Million (2025-2030)
  • Table 121. South America Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2025-2030)
  • Table 122. South America Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 123. South America Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 124. South America Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 125. Brazil Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 126. Brazil Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 127. Brazil Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 128. Argentina Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 129. Argentina Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 130. Argentina Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 131. Rest of South America Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 132. Rest of South America Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 133. Rest of South America Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 134. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2025-2030)
  • Table 135. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 136. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 137. Asia Pacific Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 138. China Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 139. China Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 140. China Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 141. Japan Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 142. Japan Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 143. Japan Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 144. India Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 145. India Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 146. India Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 147. South Korea Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 148. South Korea Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 149. South Korea Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 150. Taiwan Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 151. Taiwan Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 152. Taiwan Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 153. Australia Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 154. Australia Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 155. Australia Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 159. Europe Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2025-2030)
  • Table 160. Europe Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 161. Europe Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 162. Europe Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 163. Germany Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 164. Germany Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 165. Germany Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 166. France Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 167. France Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 168. France Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 169. Italy Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 170. Italy Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 171. Italy Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 172. United Kingdom Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 173. United Kingdom Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 174. United Kingdom Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 175. Netherlands Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 176. Netherlands Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 177. Netherlands Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 178. Rest of Europe Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 179. Rest of Europe Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 180. Rest of Europe Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 181. MEA Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2025-2030)
  • Table 182. MEA Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 183. MEA Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 184. MEA Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 185. Middle East Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 186. Middle East Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 187. Middle East Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 188. Africa Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 189. Africa Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 190. Africa Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 191. North America Health Economics And Outcomes Research (HEOR) Services, by Country USD Million (2025-2030)
  • Table 192. North America Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 193. North America Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 194. North America Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 195. United States Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 196. United States Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 197. United States Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 198. Canada Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 199. Canada Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 200. Canada Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 201. Mexico Health Economics And Outcomes Research (HEOR) Services, by Type USD Million (2025-2030)
  • Table 202. Mexico Health Economics And Outcomes Research (HEOR) Services, by Service Provider USD Million (2025-2030)
  • Table 203. Mexico Health Economics And Outcomes Research (HEOR) Services, by End User USD Million (2025-2030)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Health Economics And Outcomes Research (HEOR) Services: by Type USD Million (2018-2023)
  • Figure 5. Global Health Economics And Outcomes Research (HEOR) Services: by Service Provider USD Million (2018-2023)
  • Figure 6. Global Health Economics And Outcomes Research (HEOR) Services: by End User USD Million (2018-2023)
  • Figure 7. South America Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 8. Asia Pacific Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 9. Europe Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 10. MEA Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 11. North America Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 12. Global Health Economics And Outcomes Research (HEOR) Services share by Players 2023 (%)
  • Figure 13. Global Health Economics And Outcomes Research (HEOR) Services share by Players (Top 3) 2023(%)
  • Figure 14. Global Health Economics And Outcomes Research (HEOR) Services share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Avalon Health Economics (United States) Revenue, Net Income and Gross profit
  • Figure 17. Avalon Health Economics (United States) Revenue: by Geography 2023
  • Figure 18. McKesson Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. McKesson Corporation (United States) Revenue: by Geography 2023
  • Figure 20. Cardinal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Cardinal Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Medlior Health Outcomes Research Ltd (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Medlior Health Outcomes Research Ltd (Canada) Revenue: by Geography 2023
  • Figure 24. Optum (United States) Revenue, Net Income and Gross profit
  • Figure 25. Optum (United States) Revenue: by Geography 2023
  • Figure 26. PharmaLex (Germany) Revenue, Net Income and Gross profit
  • Figure 27. PharmaLex (Germany) Revenue: by Geography 2023
  • Figure 28. Pharmaceutical Product Development (PPD) (United States) Revenue, Net Income and Gross profit
  • Figure 29. Pharmaceutical Product Development (PPD) (United States) Revenue: by Geography 2023
  • Figure 30. IQVIA (United States) Revenue, Net Income and Gross profit
  • Figure 31. IQVIA (United States) Revenue: by Geography 2023
  • Figure 32. RTI Health Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 33. RTI Health Solutions (United States) Revenue: by Geography 2023
  • Figure 34. Global Health Economics And Outcomes Research (HEOR) Services: by Type USD Million (2025-2030)
  • Figure 35. Global Health Economics And Outcomes Research (HEOR) Services: by Service Provider USD Million (2025-2030)
  • Figure 36. Global Health Economics And Outcomes Research (HEOR) Services: by End User USD Million (2025-2030)
  • Figure 37. South America Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 38. Asia Pacific Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 39. Europe Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 40. MEA Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
  • Figure 41. North America Health Economics And Outcomes Research (HEOR) Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Avalon Health Economics (United States)
  • McKesson Corporation (United States)
  • Cardinal Health, Inc. (United States)
  • Medlior Health Outcomes Research Ltd (Canada)
  • Optum (United States)
  • PharmaLex (Germany)
  • Pharmaceutical Product Development (PPD) (United States)
  • IQVIA (United States)
  • RTI Health Solutions (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 222 Pages 75 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Avalon Health Economics (United States), McKesson Corporation (United States), Cardinal Health, Inc. (United States), Medlior Health Outcomes Research Ltd (Canada), Optum (United States), PharmaLex (Germany), Pharmaceutical Product Development (PPD) (United States), IQVIA (United States) and RTI Health Solutions (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Outsourcing of R&D Activities" is seen as one of major influencing trends for Health Economics And Outcomes Research (HEOR) Services Market during projected period 2023-2030.
The Health Economics And Outcomes Research (HEOR) Services market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Health Economics And Outcomes Research (HEOR) Services Market Report?